The Werner syndrome. A model for the study of human aging

Annals of the New York Academy of Sciences

Volumn 908, Issue , 2000, Pages 167-179

  Nehlin, Jan O ^a   Skovgaard, Gunhild Lange ^a   Bohr, Vilhelm A ^b  

^a Mental Health Center Glostrup   (Denmark)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; PROTEIN P53; REPLICATION PROTEIN A;

AGING; CAENORHABDITIS ELEGANS; CONFERENCE PAPER; DNA METABOLISM; DROSOPHILA; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; LIFESPAN; SACCHAROMYCES CEREVISIAE; SENESCENCE; WERNER SYNDROME;

CAENORHABDITIS ELEGANS; SACCHAROMYCES CEREVISIAE;

EID: 0033929776     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06645.x     Document Type: Conference Paper

References (105)

1. 1. MERCK RESEARCH LABORATORIES. 1995. Merck Manual of Geriatrics. 2nd edit. Merck & Co., Inc. Rahway, NJ.
2. 2. SALK, D. 1982. Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations. Hum. Genet. 62: 1-15.
3. 3. EPSTEIN, C.J. et al. 1966. Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 45: 177-221.
4. 4. MURATA, K. & H. NAKASHIMA. 1982. Werner's syndrome: twenty-four cases with a review of the Japanese medical literature. J. Am. Geriat. Soc. 30: 303-308.
5. 5. THWEATT, R. & S. GOLDSTEIN. 1993. Werner syndrome and biological ageing: a molecular genetic hypothesis. BioEssays 15: 421-426.
6. 6. MARTIN, G.M. 1997. Genetics and the pathobiology of ageing. Phil. Trans. R. Soc. London B. 352: 1773-1780.
7. 7. LEVERENZ, J.B. et al. 1998. Aging-associated neuropathology in Werner syndrome. Acta Neuropathol. (Berlin) 96: 421-424.
8. 8. TAKEUCHI, F. et al. 1982. Prolongation of S phase and whole cell cycle in Werner's syndrome fibroblasts. Exp. Gerontol. 17: 473-480.
9. 9. POOT, M. et al. 1992. Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp. Cell. Res. 202: 267-273.
10. 10. FUJIWARA, Y. et al. 1977. A retarded rate of DNA replication and normal level of DNA repair in Werner's syndrome fibroblasts in culture. J. Cell. Physiol. 92: 365-374.
11. 11. SALK, D. et al. 1981. Evidence of clonal attenuation, clonal succession, and clonal expansion in mass cultures of aging Werner's syndrome skin fibroblasts. Cytogenet. Cell Genet. 30: 108-117.
12. 12. HOEHN, H. et al. 1975. Variegated translocation mosaicism in human skin fibroblast cultures. Cytogenet. Cell Genet. 15: 282-298.
13. 13. NORDENSON, I. 1977. Chromosome breaks in Werner's syndrome and their prevention in vitro by radical-scavenging enzymes. Hereditas 87: 151-154.
14. 14. GEBHART, E. et al. 1988. Spontaneous and induced chromosomal instability in Werner syndrome. Hum. Genet. 80: 135-139.
15. 15. SCAPPATICCI, S. et al. 1982. Clonal structural chromosomal rearrangements in primary fibroblast cultures and in lymphocytes of patients with Werner's syndrome. Hum. Genet. 62: 16-24.
16. 16. SCHONBERG, S. et al. 1984. Werner's syndrome: proliferation in vitro of clones of cells bearing chromosome translocations. Am. J. Hum. Genet. 36: 387-397.
17. 17. FUKUCHI, K. et al. 1989. Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl. Acad. Sci. USA 86: 5893-5897.
18. 18. SCHULZ, V.P. et al. 1996. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum. Genet. 97: 750-754.
19. 19. TAHARA, H. et al. 1997. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15: 1911-1920.
20. 20. RÜNGER, T.M. et al. 1994. Hypermutable ligation of plasmid DNA ends in cells from patients with Werner syndrome. J. Invest. Dermatol. 102: 45-48.
21. 21. WEBB, D.K. et al. 1996. DNA repair fine structure in Werner's syndrome cell lines. Exp. Cell Res. 224: 272-278.
22. 22. WEIRICH-SCHWAIGER, H. et al. 1994. Correlation between senescence and DNA repair in cells from young and old individuals and in premature aging syndromes. Mut. Res. 316: 37-48.
23. 23. FUKUCHI, K. et al. 1990. Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients. Hum. Genet. 84: 249-252.
24. 24. KYOIZUMI, S. et al. 1998. In vivo somatic mutations in Werner's syndrome. Hum. Genet. 103: 405-410.
25. 25. KRUK, P.A. et al. 1995. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. USA 92: 258-262.
26. 26. OGBURN, C.E. et al. 1997. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum. Genet. 101: 121-125.
27. 27. OKADA, M. et al. 1998. Differential effects of cytotoxic drugs on normal and immortalised B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol. Pharm. Bull. 21: 235-239.
28. 28. POOT, M. et al. 1999. Werner syndrome lymphoblastoid cells are sensitive to camp-tothecin-induced apoptosis in S-phase. Hum. Genet. 104: 10-14.
29. 29. CHAKRAVERTY, R.K. & I.D. HICKSON. 1999. Defending genome integrity during DNA replication: a proposed role for RecQ family helicases. Bioessays 21: 286-294.
30. 30. BALAJEE, A.S. et al. 1999. The Werner syndrome protein is involved in RNA polymerase II transcription. Mol. Biol. Cell 10: 2655-2668.
31. 31. YU, C.-E. et al. 1996. Positional cloning of the Werner's syndrome gene. Science 272: 258-262.
32. 32. OSHIMA, J. et al. 1996. Homozygous and compound heterozygous mutations at the Werner syndrome locus. Hum. Mol. Gen. 5: 1909-1913.
33. 33. GOTO, M. et al. 1997. Analysis of helicase gene mutations in Japanese Werner's syndrome patients. Hum. Genet. 99: 191-193.
34. 34. YU, C.-E. et al. 1997. Mutations in the consensus helicase domains of the Werner syndrome gene. Am. J. Hum. Genet. 60: 330-341.
35. 35. MATSUMOTO, T. et al. 1997. Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population. Hum. Genet. 100: 123-130.
36. 36. MEISSLITZER, C. et al. 1997. Werner syndrome: characterization of mutations in the WRN gene in an affected family. Eur. J. Hum. Genet. 5: 364-370.
37. 37. MOSER, M.J. et al. 1999. WRN mutations in Werner syndrome. Hum. Mutat. 13: 271-279.
38. 38. YE, L. et al. 1997. Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population. Am. J. Med. Genet. 68: 494-498.
39. 39. CASTRO, E. et al. 1999. Polymorphisms at the Werner locus: I. Newly identified polymorphisms, ethnic variability of 1367Cy/Arg, and its stability in a population of Finnish centenarians. Am. J. Med. Genet. 82: 399-403.
40. 40. MOROZOV, V. et al. 1997. A putative nucleic acid-binding domain in Bloom's and Werner's syndrome helicases. Trends Biochem. Sci. 22: 417-418.
41. 41. HUANG, S. et al. 1998. The premature ageing syndrome protein, WRN, is a 3′ → 5′ exonuclease. Nat. Genet. 20: 114-116.
42. 42. KUSANO, K. et al. 1999. Evolution of the RECQ family of helicases: a drosophila homolog, Dmblm, is similar to the human bloom syndrome gene. Genetics 151: 1027-1039.
43. 43. STEWART, E. et al. 1997. rqhI+, a fission yeast gene related to the Bloom's and Werner's syndrome genes, is required for reversible S phase arrest. EMBO J. 16: 2682-2692.
44. 44. YAN, H. et al. 1998. Replication focus-forming activity 1 and the Werner syndrome gene product. Nat. Genet. 19: 375-378.
45. 45. SEKELSKY, J.J. et al. 1999. Drosophila and human RecQ5 exist in different isoforms generated by alternative splicing. Nucleic Acids Res. 27: 3762-3769
46. 46. KITAO, S. et al. 1998. Cloning of two new human helicase genes of the RecQ family: biological significance of multiple species in higher eukaryotes. Genomics 54: 443-452.
47. 47. KITAO, S. et al. 1999. Mutations in RECQ4L cause a subset of cases of Rothmund-Thomson syndrome. Nat. Genet. 22: 82-84.
48. 48. YAMABE, Y. et al. 1997. Down-regulation of the defective transcripts of the Werner's syndrome gene in the cells of patients. Biochem. Biophys. Res. Comm. 236: 151-154.
49. 49. MURANO, S. et al. 1984. Diverse gene sequences are overexpressed in Werner syndrome fibrblasts undergoing premature replicative senescence. Mol. Cell. Biol. 11: 3905-3914.
50. 50. TODA, T. et al. 1998. A comparative analysis of the proteins between the fibroblasts from Werner's syndrome patients and age-matched normal individuals using two-dimensional gel electrophoresis. Mech. Ageing Dev. 100: 133-143.
51. 51. MATUOKA, K. & T. TAKENAWA. 1998. Downregulated expression of the signaling molecules Nek, c-Crk, Grb2/Ash, PI 3-kinase p110 alpha and WRN during fibroblast aging in vitro. Biochim. Biophys. Acta 1401: 211-215.
52. 52. YAMABE, Y. et al. 1998. Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53. Mol. Cell Biol. 18: 6191-6200.
53. 53. WANG, L. et al. 1998. Structure and function of the human Werner syndrome gene promoter: evidence for transcriptional modulation. Nucl. Acids Res. 26: 3480-3485.
54. 54. SHIRATORI, M. et al. 1999. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J. Cell. Biol. 144: 1-9.
55. 55. SPILLARE, E.A. et al. 1999. p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev. 13: 1355-1360.
56. 56. LEBEL, M. & P. LEDER. 1998. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. USA 95: 13097-13102.
57. 57. WU, J. et al. 1998. Effect of age and apoptosis on the mouse homologue of the huWRN gene. Mech. Ageing Dev. 103: 27-44.
58. 58. MATSUMOTO, T. et al. 1997. Impaired nuclear localization of defective DNA helicases in Werner's syndrome. Nat. Genet. 16: 335-336.
59. 59. MATSUMOTO, T. et al. 1998. Characterization of the nuclear localization signal in the DNA helicase involved in Werner's syndrome. Int. J. Mol. Med. 1: 71-76.
60. 60. GRAY, M.D. et al. 1998. Werner helicase is localized to transcriptionally active nucleoli of cycling cells. Exp. Cell Res. 242: 487-494.
61. 61. MARCINIAK, R.A. et al. 1998. Nucleolar localization of the Werner syndrome protein in human cells. Proc. Natl. Acad. Sci. USA 95: 6887-6892.
62. 62. GRAY, M.D. et al. 1997. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17: 100-103.
63. 63. SUZUKI, N. et al. 1997. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucl. Acids Res. 25: 2973-2978.
64. 64. SHEN, J.-C. et al. 1998. Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res. 26: 2879-2885.
65. 65. BROSH, R.M., JR. et al. 1999. Functional and physical interaction between WRN helicase and human replication protein A. J. Biol. Chem. 274: 18341-18350.
66. 66. ORREN, D.K. et al. 1999. Enzymatic and DNA binding properties of purified WRN protein: high affinity binding to single-stranded DNA but not to DNA damage induced by 4NQO. Nucleic Acids Res. 27: 3557-3566.
67. 67. FRY, M. & L.A. LOEB. 1999. Human Werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J. Biol. Chem. 274: 12797-12802.
68. 68. KAMATH-LOEB, A.S. et al. 1998. Werner syndrome protein.II. Characterization of the integral 3′-5′ DNA exonuclease. J. Biol. Chem. 273: 34145-34150.
69. 69. SHEN, J.C. et al. 1998. Werner syndrome protein.I. Dna helicase and dna exonuclease reside on the same polypcptide. J. Biol. Chem. 51: 34139-34144.
70. 70. SUZUKI, N. et al. 1999. Werner syndrome helicase contains a 5′ → 3′ exonuclease activity that digests DNA and RNA strands in DNA/DNA and RNA/DNA duplexes dependent on unwinding. Nucleic Acids Res. 27: 2361-2368.
71. 71. WOLD, M.S. 1997. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Ann. Rev. Biochem. 66: 61-92.
72. 72. WALTHER, A.P. et al. 1999. Replication protein A interactions with DNA. 1. Functions of the DNA-binding and zinc-finger domains of the 70-kDa subunit. Biochemistry 38: 3963-3973.
73. 73. BOCHKAREV, A. et al. 1999. The crystal structure of the complex of replication protein A subunits RPA32 and RPA14 reveals a mechanism for single-stranded DNA binding. EMBO J. 18: 4498-4504.
74. 74. ADACHI, Y. & U.K. LAEMMLL. 1992. Identification of nuclear pre-replication centers poised for DNA synthesis in Xenopus egg extracts: immunolocalization study of replication protein A. J. Cell. Biol. 119: 1-15.
75. 75. CARDOSO, M.C. et al. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74: 979-992.
76. 76. MURTI, K.G. et al. 1996. Dynamics of human replication protein A subunit distribution and partitioning in the cell cycle. Exp. Cell. Res. 223: 279-289.
77. 77. BRAUN, K.A. et al. 1997. Role of protein-protein interactions in the function of replication protein A (RPA): RPA modulates the activity of DNA polymerase alfa by multiple mechanisms. Biochemistry 36: 8443-8454.
78. 78. WEISSHART, K. et al. 1998. The replication protein A binding site in simian virus 40 (SV40) T antigen and its role in the initial steps of SV40 DNA replication. J. Virol. 72: 9771-9781.
79. 79. HAN, Y. et al. 1999. Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J. Virol. 73: 4899-4907.
80. 80. WALTHER, A.P. et al. 1999. A novel assay for examining the molecular reactions at the eukaryotic replication fork: activities of replication protein A required during elongation. Nucleic Acids Res. 27: 656-664.
81. 81. YE, L. et al. 1998. Transcriptional activation by the Werner syndrome gene product in yeast. Exp. Gerontol. 33: 805-812.
82. 82. YAMAGATA, K. et al. 1998. Bloom's and Werner's syndrome genes suppress hyper-recombination in yeast sgsI mutant: implication for genomic instability in human diseases. Proc. Natl. Acad. Sci. USA 95: 8733-8738.
83. 83. GANGLOFF, S. et al. 1994. The yeast type I topoisomerase Top3 interacts with SgsI, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol. Cell. Biol. 14: 8391-8398.
84. 84. WATT, P.M. et al. 1995. SgsI: a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell 81: 253-260.
85. 85. JOHNSON, F.B. et al. 1999. Molecular biology of aging. Cell 96: 291-302.
86. 86. PARK, M.S. et al. 1996. Physical interaction between human RAD52 and RPA is required for homologous recombination in mammalian cells. J. Biol. Chem. 271: 18996-19000.
87. 87. BAUMANN, P. & S.C. WEST. 1997. The human Rad51 protein: polarity of strand transfer and stimulation by hRP-A. EMBO J. 16: 5198-5206.
88. 88. GOLUB, E.I. et al. 1998. Interaction of human Rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucl. Acids Res. 26: 5388-5393.
89. 89. HIGASHIKAWA, T. & Y. FUJIWARA. 1978. Normal level of unscheduled DNA synthesis in Werner's syndrome fibroblasts in culture. Exp. Cell Res. 113: 438-442.
90. 90. SALK, D. et al. 1981. Effects of radical-scavenging enzymes and reduced oxygen exposure on growth and chromosome abnormalities of Werner syndrome cultured skin fibroblasts. Hum. Genet. 57: 269-275.
91. 91. KODAMA, S. et al. 1998. Failure to complement abnormal phenotypes of simian virus 40-transformed Werner syndrome cells by introduction of a normal human chromosome 8. Cancer Res. 58: 5188-5195.
92. 92. PATRICK, S.M. & J.M. TURCHI. 1999. Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA. J. Biol. Chem. 274: 14972-14978.
93. 93. STIGGER, E. et al. 1998. Functional analysis of human replication protein A in nucleotide excision repair. J. Biol. Chem. 273: 9337-9343.
94. 94. TREUNER, K. et al. 1998. Chromatin association of replication protein A. J. Biol. Chem. 273: 31744-31750.
95. 95. LIN, Y.-L. et al. 1998. The evolutionary conserved zinc finger motif in the largest subunit of human replication protein A is required for DNA replication and mismatch repair but not for nucleotide excision repair. J. Biol. Chem. 273: 1453-1461.
96. 96. GANGULY, T. & N.J. DUKER. 1992. Reduced 5-hydroxymethyluracil-DNA glycosylase activity in Werner's syndrome cells. Mutat. Res. 275: 87-96.
97. 97. TREUNER, K. et al. 1999. Phosphorylation of replication protein A middle subunit (RPA32) leads to a disassembly of the RPA heterotrimer. J. Biol. Chem. 274: 15556-15561.
98. 98. GATELY, D.P. et al. 1998. Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity. Mol. Biol. Cell 9: 2361-2374.
99. 99. CHENG, X. et al. 1996. Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in aged normal fibroblasts. Radiother. Oncol. 39: 43-52.
100. 100. SHAO, R.G. et al. 1999. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J. 18: 1397-1406.
101. 101. WANG, Y. et al. 1999. Roles of replication protein A and DNA-dependent protein kinase in the regulation of DNA replication following DNA damage. J. Biol. Chem. 274: 22060-22064.
102. 102. SMITH, G.C.M. & S.P. JACKSON. 1999. The DNA-dependent protein kinase. Genes Dev. 13: 916-934.
103. 103. DIMRI, G.P. et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92: 9363-9367.
104. 104. WARNER, H.R. & T.E. JOHNSON. 1997. Parsing age, mutations and time. Nat. Genet. 17: 368-370.
105. 105. OSHIMA, J. et al. 1995. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J. Cell. Physiol. 162: 277-283.